Phillip Chan

Phillip Chan

Chief Executive Officer at CYTOSORBENTS CORPORATION

Net worth: 942 246 $ as of 29/04/2024

53 year
Health Technology
Consumer Services
Finance

Network origin in Phillip Chan first degree

EntityEntity typeIndustry
Public Company Medical Specialties 27
1
Subsidiary Medical Distributors 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Phillip Chan via their personal network

CompanySectorRelated peopleMain position
College/University

Joseph Rubin

Eric G. Mortsenson

Graduate Degree

Doctorate Degree

The Medical Education Institute, Inc.

Al Kraus

Edward Jones

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Alex D’Amico

Alan Sobel

Corporate Officer/Principal

Director/Board Member

St. Joseph's University College/University

Al Kraus

Edward Jones

Undergraduate Degree

Masters Business Admin

The Wharton School of the University of Pennsylvania College/University

Michael Bator

Jiny Kim

Masters Business Admin

Undergraduate Degree

Princeton University College/University

Michael Bator

Gregory DiRusso

Undergraduate Degree

Undergraduate Degree

Belarusian State University of Informatics & Radioelectronics College/University

Irina B. Kulinets

Graduate Degree

Miscellaneous Commercial Services

Irina B. Kulinets

Corporate Officer/Principal

Medical Specialties

Irina B. Kulinets

General Counsel

ANIKA THERAPEUTICS, INC. Medical Specialties

Irina B. Kulinets

Chief Tech/Sci/R&D Officer

TELARIA, INC. Packaged Software

Alex D’Amico

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Alex D’Amico

Corporate Officer/Principal

Miscellaneous Commercial Services

Alex D’Amico

Corporate Officer/Principal

TRULIEVE CANNABIS CORP. Agricultural Commodities/Milling

Alex D’Amico

Director of Finance/CFO

Miscellaneous Commercial Services

Alex D’Amico

Corporate Officer/Principal

HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. Medical Specialties

Irina B. Kulinets

General Counsel

Pharmaceuticals: Major

Alex D’Amico

Comptroller/Controller/Auditor

Rutgers State University of New Jersey College/University

Alex D’Amico

Undergraduate Degree

SYNVISTA THERAPEUTICS, INC. Pharmaceuticals: Major

Alex D’Amico

Comptroller/Controller/Auditor

Medical/Nursing Services

Edward Jones

Corporate Officer/Principal

Delaware Valley Nephrology & Hypertension Associates

Edward Jones

Chief Executive Officer

National Kidney Foundation of The Delaware Valley

Edward Jones

Director/Board Member

Medical University of South Carolina College/University

Edward Jones

Undergraduate Degree

Medical/Nursing Services

Edward Jones

Chairman

Hospital/Nursing Management

Edward Jones

Corporate Officer/Principal

The Philadelphia County Medical Society

Edward Jones

Corporate Officer/Principal

Miscellaneous Commercial Services

Edward Jones

President

Packaged Software

Joseph Rubin

Chief Executive Officer

Rubin & Bailin LLP

Joseph Rubin

Founder

California State University-Dominguez Hills College/University

Irina B. Kulinets

Graduate Degree

Building Products

Kathleen Bloch

Director of Finance/CFO

Medical Specialties

Irina B. Kulinets

General Counsel

Miscellaneous Commercial Services

Alan Sobel

Corporate Officer/Principal

The College of Arts & Sciences College/University

Jiny Kim

Undergraduate Degree

ZIMMER BIOMET HOLDINGS, INC. Medical Specialties

Jiny Kim

Corporate Officer/Principal

MIT Sloan School of Management College/University

Jiny Kim

Masters Business Admin

Biotechnology

James Komsa

Corporate Officer/Principal

U.S. Pain Foundation, Inc.

James Komsa

Corporate Officer/Principal

Restorative Therapy Group

James Komsa

Corporate Officer/Principal

National & Kapodistrian University of Athens College/University

Efthymios Deliargyris

Doctorate Degree

Wake Forest University College/University

Efthymios Deliargyris

Corporate Officer/Principal

ATHENS MEDICAL C.S.A. Hospital/Nursing Management

Efthymios Deliargyris

Corporate Officer/Principal

PLX PHARMA WINDDOWN CORP. Pharmaceuticals: Major

Efthymios Deliargyris

Chief Tech/Sci/R&D Officer

PFIZER, INC. Pharmaceuticals: Major

Eric G. Mortsenson

Corporate Officer/Principal

Harvard College College/University

Eric G. Mortsenson

Undergraduate Degree

Ludwig-Maximilians-Universität München College/University

Volker Humbert

Doctorate Degree

Fairleigh Dickinson University College/University

Alan Sobel

Graduate Degree

Statistics

International

United States 46
Greece 3
Belarus 2
Germany 2

Sectoral

Consumer Services 16
Health Technology 12
Commercial Services 10
Health Services 5
Technology Services 3

Operational

Corporate Officer/Principal 34
Director/Board Member 30
Undergraduate Degree 19
Director of Finance/CFO 18
President 12